Objectives:
1. Learn the importance of an early molecular response,
2) Understand treatment recommendations,
3) Review the outcomes from prospective discontinuation trials
Session date:
03/06/2017 - 12:00pm to 1:00pm CST
Location:
UCMC
KCBD
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Richard Larson & Daniel Catenacci, M.D